Bayer sells its interest in titanium dioxide joint venture
At the beginning of 1998 Bayer sought to achieve a sustained improvement in the competitive position of its titanium dioxide business unit in the face of difficult market conditions. In Kerr-McGee, with its global titanium dioxide business, Bayer found a partner that offers the business good long-term prospects from both the economic and technological points of view, thereby safeguarding the future of the production facilities at Krefeld-Uerdingen, Germany and Antwerp, Belgium.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.